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Background: As meaningful survival with left ventricular assist device(LAVD) therapy becomes reality, it would be important to contain cost by 
understanding factors that influence the hospital length of stay (LOS). Therefore, we conducted this study reviewing our recent LVAD experience.
Methods: During the past 2.5 years, we identified 64 patients, 32 bridge to transplant(BTT) and 32 destination therapy(DT) who were discharged 
alive following LVAD implantation. Various demographic, clinical and hemodynamic parameters were examined for their influence on LOS.
Results: The mean age for the entire cohort was 60.0±14.3. The mean and median LOS was 21.6±14.3 and 17 days respectively. Patient’s 
preoperative conditions such as redo sternotomy (26.6±18.8 vs 18.5±9.8 p=0.03), peak VO2 (r=-0.36 p=0.003), or high BNP levels (r=0.3 p=0.02) 
were associated with significantly increased LOS. A pulsatile LVAD was associated with increased LOS compared to a continuous LVAD (44.0±36.3 
vs 20.0±10.5 p=0.04). There was a trend toward increased LOS for the patients receiving inotropic support before surgery (24.1±2.3 vs 18.3±3.8 
p=0.19). Age, ejection fraction, serum creatinine, mean pulmonary artery pressure, right atrial pressure, left ventricular end diastolic diameter, 
cardiac index, etiology of cardiomyopathy (ischemic v. non-ischemic) or the indication for LVAD (BTT v. DT) did not influence the LOS. In multivariate 
analysis, peak VO2, BNP, inotropic support and a pulsatile LVAD were the significant independent predictors of increased LOS.
Conclusions: The hospital LOS following LVAD implantation is now considerably shorter than what was reported with pulsatile pumps. Nonetheless, 
increased LOS seems to be most common in patients with the worst cardiac reserve at the time of LVAD implantation. Timely referral to LVAD 
therapy, during the continuum of care for advanced heart failure patients, may reduce the cost.
